Lung CD57+ cell density is increased in very severe COPD

dc.contributor.authorOlloquequi, Jordi
dc.contributor.authorGarcia Valero, Josep
dc.contributor.authorRodríguez, Esther
dc.contributor.authorMontero, M. Angeles
dc.contributor.authorFerrer Sancho, Jaume, 1958-
dc.contributor.authorMontes Castillo, Juan Francisco
dc.date.accessioned2014-05-05T13:58:54Z
dc.date.available2014-05-05T13:58:54Z
dc.date.issued2012
dc.date.updated2014-05-05T13:58:54Z
dc.description.abstractAmong all inflammatory cells involved in COPD, those with a cytolytic or elastolytic activity are thought to play a key role in the pathogenesis of the disease. However, there is no data about the infiltration of cells expressing the CD57 marker in small airways and parenchyma of COPD patients. In this study, surgical specimens from 43 subjects undergoing lung resection due to lung cancer (9 non-smokers, 18 smokers without COPD and 16 smokers with moderate COPD) and 16 patients undergoing double lung transplantation for very severe COPD were examined. CD57+ cells, neutrophils, macrophages and mast cells infiltrating bronchioles (epithelium, smooth muscle and connective tissue) and parenchymal interstitium were localized and quantified by immunohistochemical analysis. Compared to the other groups, the small airways of very severe COPD patients showed a significantly higher density of CD57+ cells, mainly infiltrated in the connective tissue (p=0.001), and a significantly higher density of neutrophils located characteristically in the epithelium (p=0.037). Also, the density of neutrophils was significantly higher in parenchyma of very severe COPD patients compared with the rest of the groups (p=0.001). Finally, there were significant correlations between the bronchiolar density of CD57+ cells and the FEV1 values (R=-0.43, p=0.022), as well as between the parenchymal density of neutrophils and macroscopic emphysema degree (R=0.43, p=0.048) in COPD groups. These results show that CD57+ cells may be involved in COPD pathogenesis, especially in the most severe stages of the disease.
dc.format.extent9 p.
dc.format.mimetypeapplication/pdf
dc.identifier.idgrec595005
dc.identifier.issn0213-3911
dc.identifier.urihttps://hdl.handle.net/2445/53850
dc.language.isoeng
dc.publisherSercrisma International
dc.relation.isformatofReproducció del document publicat a: http://doi.org/10.14670/HH-27.39
dc.relation.ispartofHistology and Histopathology, 2012, vol. 27, num. 1, p. 39-47
dc.relation.urihttp://doi.org/10.14670/HH-27.39
dc.rights(c) Sercrisma International, 2012
dc.rights.accessRightsinfo:eu-repo/semantics/openAccess
dc.sourceArticles publicats en revistes (Biologia Cel·lular, Fisiologia i Immunologia)
dc.subject.classificationMalalties pulmonars obstructives cròniques
dc.subject.classificationMalalties del pulmó
dc.subject.classificationCàncer de pulmó
dc.subject.classificationCèl·lules canceroses
dc.subject.otherChronic obstructive pulmonary diseases
dc.subject.otherPulmonary diseases
dc.subject.otherLung cancer
dc.subject.otherCancer cells
dc.titleLung CD57+ cell density is increased in very severe COPD
dc.typeinfo:eu-repo/semantics/article
dc.typeinfo:eu-repo/semantics/publishedVersion

Fitxers

Paquet original

Mostrant 1 - 1 de 1
Carregant...
Miniatura
Nom:
595005.pdf
Mida:
2.37 MB
Format:
Adobe Portable Document Format